{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:54:24Z","timestamp":1785034464695,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["AD23026252"],"award-info":[{"award-number":["AD23026252"]}],"id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFAA069585"],"award-info":[{"award-number":["2025GXNSFAA069585"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009007","name":"Guangxi Normal University","doi-asserted-by":"publisher","award":["CMEMR2020-A10"],"award-info":[{"award-number":["CMEMR2020-A10"]}],"id":[{"id":"10.13039\/501100009007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019006","name":"State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118874","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:42:59Z","timestamp":1776440579000},"page":"118874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and anti-Alzheimer's disease activity evaluation of dual 17\u03b2-HSD10 and CDK5\/p25 inhibitors based on the naphtho[2,3-b]furan-4,9-dione scaffold"],"prefix":"10.1016","volume":"313","author":[{"given":"Shiyun","family":"Dao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-276X","authenticated-orcid":false,"given":"Huang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118874_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jsbmb.2014.07.001","article-title":"Roles of 17\u03b2-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders","volume":"143","author":"Yang","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118874_bib2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1101\/gad.268482.115","article-title":"Human HSD10 are cardiolipin phospholipases","volume":"29","author":"Shimkets","year":"2015","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2026.118874_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3233\/JAD-220481","article-title":"3-Hydroxyacyl-CoA and alcohol dehydrogenase activities of mitochondrial type 10 17\u03b2-Hydroxysteroid dehydrogenase in neurodegeneration study","volume":"88","author":"He","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.118874_bib4","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.jmedchem.8b01530","article-title":"Amyloid-binding alcohol dehydrogenase (ABAD) inhibitors for the treatment of Alzheimer's disease","volume":"62","author":"Morsy","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-170974","article-title":"Roles of mitochondrial 17\u03b2-Hydroxysteroid dehydrogenase type 10 in Alzheimer's disease","volume":"62","author":"He","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.118874_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jnc.15027","article-title":"Friend or enemy? Review of 17\u03b2-HSD10 and its role in human health or disease","volume":"155","author":"Vinklarova","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.118874_bib7","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/ijms21062059","article-title":"Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17\u03b2-HSD10 with implications to Alzheimer's disease treatment","volume":"21","author":"Schmidt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj20030877","article-title":"Expanded substrate screenings of human and Drosophila type 10 17\u03b2-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3\u03b1\/7\u03b1\/7\u03b2\/17\u03b2\/20\u03b2\/21-HSD","volume":"376","author":"Naeem","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.118874_bib9","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0040-22.2022","article-title":"The mitochondrial enzyme 17\u03b2HSD10 modulates ischemic and amyloid-\u03b2-induced stress in primary mouse astrocytes","volume":"9","author":"Metodieva","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.ejmech.2026.118874_bib10","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.bmcl.2018.09.031","article-title":"Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17\u03b2-hydroxysteroid dehydrogenase type 10","volume":"28","author":"Boutin","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118874_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/1573406413666170109142725","article-title":"6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD\/17\u03b2-HSD10 and potential drugs for Alzheimer's disease treatment: design, synthesis and in vitro evaluation","volume":"13","author":"Benek","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24152757","article-title":"Novel benzothiazole-based ureas as 17\u03b2-HSD10 inhibitors, A potential Alzheimer's disease treatment","volume":"24","author":"Aitken","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118874_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/2472555217697964","article-title":"In vitro assay development and HTS of small-molecule human ABAD\/17\u03b2-HSD10 inhibitors as therapeutics in Alzheimer's disease","volume":"22","author":"Aitken","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2026.118874_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112909","article-title":"Synthesis of 17\u03b2-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency","volume":"209","author":"Boutin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2009.05.001","article-title":"Recent advances in understanding the roles of Cdk5 in synaptic plasticity","volume":"1792","author":"Lai","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2026.118874_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.03.006","article-title":"Cdk5: multitasking between physiological and pathological conditions","volume":"94","author":"Lopes","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.118874_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-180792","article-title":"CDK5: a unique CDK and its multiple roles in the nervous system","volume":"68","author":"Cort\u00e9s","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.118874_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-6598-4_11","article-title":"The study of posttranslational modifications of tau protein by nuclear magnetic resonance spectroscopy: phosphorylation of tau protein by ERK2 recombinant kinase and rat brain extract, and acetylation by recombinant creb-binding protein","volume":"1523","author":"Qi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118874_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118874_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109504","article-title":"Sulforaphene, a CDK5 inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing abeta deposition, tau hyperphosphorylation and synaptic dysfunction","volume":"114","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118874_bib21","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.0621-17.2017","article-title":"Inhibition of p25\/Cdk5 attenuates tauopathy in mouse and iPSC models of frontotemporal dementia","volume":"37","author":"Seo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118874_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.omtn.2021.11.019","article-title":"Implications of miR-148a-3p\/p35\/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt\/CREB in Alzheimer's disease","volume":"27","author":"Zeng","year":"2022","journal-title":"Mol. Ther-Nucl. Acids"},{"key":"10.1016\/j.ejmech.2026.118874_bib23","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/hmg\/ddz120","article-title":"Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262","volume":"28","author":"Taro","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2026.118874_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41418-020-00620-y","article-title":"RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118874_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm049323m","article-title":"Mechanism of CDK5\/p25 binding by CDK inhibitors","volume":"48","author":"Mapelli","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2016.06.040","article-title":"Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells","volume":"628","author":"Liu","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2026.118874_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2015.08.099","article-title":"Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro","volume":"98","author":"Cihalova","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118874_bib28","first-page":"135\/1","article-title":"Roscovitine in cancer and other diseases","volume":"3","author":"Cicenas","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118874_bib29","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.ejca.2010.08.001","article-title":"Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies","volume":"46","author":"Le Tourneau","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.118874_bib30","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/qua.21716","article-title":"Computational optimization of AG18051 inhibitor for amyloid-\u03b2 binding alcohol dehydrogenase enzyme","volume":"108","author":"Marques","year":"2008","journal-title":"Int. J. Quant. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib31","series-title":"Agouron Pharmaceuticals","article-title":"Preparation of pyrazolo[3,4-d]pyrimidine derivatives, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity","author":"Abreo","year":"2002"},{"key":"10.1016\/j.ejmech.2026.118874_bib32","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.bmcl.2006.05.099","article-title":"Identification of small-molecule inhibitors of the A\u03b2-ABAD interaction","volume":"16","author":"Xie","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118874_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cbdd.12068","article-title":"Structure-based design and synthesis of benzothiazole phosphonate analogs with inhibitors of human ABAD-A\u03b2 for treatment of Alzheimer's disease","volume":"81","author":"Valasani","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.118874_bib34","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.bmcl.2016.05.087","article-title":"Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD\/17\u03b2-HSD10 modulators for Alzheimer's disease treatment","volume":"26","author":"Hroch","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118874_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0040-4020(66)80038-8","article-title":"The constituents of Cacalia decomposita. Structures of maturin, maturinin, maturone, and maturinone","volume":"22","author":"Correa","year":"1966","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.118874_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(01)00707-8","article-title":"Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants","volume":"174","author":"Itoigawa","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118874_bib37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/np030450f","article-title":"Antitumor agents. 233.Lantalucratins A-F, new cytotoxic naphthoquinones from Lantana involucrata","volume":"67","author":"Hayashi","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118874_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-3542(97)00058-2","article-title":"Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus","volume":"37","author":"Takegami","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.118874_bib39","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1021\/jo01022a052","article-title":"Reaction of 2,3-dichloronaphthoquinone with nucleophiles. II. Reaction with ethyl acetoacetate","volume":"30","author":"Reynolds","year":"1965","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib41","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1002\/jps.21745","article-title":"In vivo, in vitro and in silico methods for small molecule transfer across the BBB","volume":"98","author":"Jurgen","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2010.01.003","article-title":"Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability","volume":"74","author":"Mensch","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2026.118874_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/cmdc.201200129","article-title":"Identification of a 17\u03b2-Hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer's disease and prostate cancer","volume":"7","author":"Ayan","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.118874_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/magnetochemistry4030032","article-title":"Structure confirmation and evaluation of a nonsteroidal inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 10","volume":"4","author":"Boutin","year":"2018","journal-title":"Magnetochemistry"},{"key":"10.1016\/j.ejmech.2026.118874_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.863762","article-title":"Systemic administration of a brain permeable Cdk5 inhibitor alters neurobehavior","volume":"13","author":"Umfress","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118874_bib46","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1080\/07391102.2020.1844050","article-title":"Identification of small molecules against cyclin dependent kinase-5 using chemoinformatics approach for Alzheimer's disease and other tauopathies","volume":"40","author":"Shukla","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2026.118874_bib47","first-page":"29","article-title":"Molecular modeling studies of triazolyl thiophenes as CDK5\/P25 inhHibitors using 3D-QSAR and molecular docking, Iran","volume":"8","author":"Garkani-Nejad","year":"2021","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.csbj.2019.04.010","article-title":"Computational simulations identified two candidate inhibitors of Cdk5\/p25 to abrogate tau-associated neurological disorders","volume":"17","author":"Zeb","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2026.118874_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/jmbi.2000.4139","article-title":"Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)\/Amyloid-\u03b2 binding alcohol dehydrogenase (ABAD)11Edited by I. A. Wilson","volume":"303","author":"Powell","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118874_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jmb.2004.07.071","article-title":"Crystal structure of human ABAD\/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics","volume":"342","author":"Kissinger","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118874_bib51","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1016\/j.bmc.2008.09.043","article-title":"Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme","volume":"16","author":"Marques","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118874_bib52","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.3390\/ijms22158096","article-title":"Roscovitine, a cyclin-dependent Kinase-5 inhibitor, decreases phosphorylated tau formation and death of retinal ganglion cells of rats after optic nerve crush","volume":"22","author":"Hirokawa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2019.05.016","article-title":"ABAD\/17\u03b2-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP\/PS1 mice","volume":"81","author":"Xiao","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2026.118874_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00415-025-13101-4","article-title":"Advances in research on mitochondrial dysfunction in neurodegenerative diseases","volume":"272","author":"Zhang","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejmech.2026.118874_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/cells14030229","article-title":"Mitochondrial alterations, oxidative stress, and therapeutic implications in Alzheimer's disease: a narrative review","volume":"14","author":"Spina","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.118874_bib56","doi-asserted-by":"crossref","first-page":"8962","DOI":"10.1038\/s41598-020-65570-4","article-title":"Comparative effects of Alpha- and gamma-tocopherol on mitochondrial functions in Alzheimer's disease in vitro model","volume":"10","author":"Pahrudin Arrozi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118874_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejmech.2026.118874_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/ars.2016.6810","article-title":"Peroxiredoxin 5 decreases beta-amyloid-mediated cyclin-dependent kinase 5 activation through regulation of Ca2+-Mediated calpain activation","volume":"27","author":"Park","year":"2017","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejmech.2026.118874_bib60","article-title":"Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+\/Calpain\/Cdk5-mediated mitochondrial fragmentation","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118874_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-5362.394816","article-title":"The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review","volume":"19","author":"Abdollahi","year":"2024","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120986","article-title":"Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: mechanisms and possible therapeutic interventions","volume":"308","author":"Maitra","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib63","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118874_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005072-199802000-00002","article-title":"Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain","volume":"57","author":"Bahr","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2026.118874_bib65","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","article-title":"Mitigating the associations of kidney dysfunction with blood biomarkers of alzheimer disease by using phosphorylated Tau to total Tau ratios","volume":"5","author":"Janelidze","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2026.118874_bib66","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/ijms26094271","article-title":"From synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine","volume":"26","author":"Toader","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118874_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12017-025-08857-x","article-title":"Unlocking Alzheimer's disease: the role of BDNF signaling in neuropathology and treatment","volume":"27","author":"Alqahtani","year":"2025","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ejmech.2026.118874_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10048-025-00821-y","article-title":"Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms","volume":"26","author":"Abbas","year":"2025","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ejmech.2026.118874_bib69","first-page":"984","article-title":"Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in Alzheimer's disease, CNS neurol","volume":"23","author":"Amidfar","year":"2024","journal-title":"Disord-DR."},{"key":"10.1016\/j.ejmech.2026.118874_bib70","first-page":"104","article-title":"Mechanism of promoting BDNF expression in brain of Alzheimer's disease patients through exercise training, Chin","volume":"41","author":"Wang","year":"2025","journal-title":"J. Neuroanat."},{"key":"10.1016\/j.ejmech.2026.118874_bib71","first-page":"1","article-title":"Microbiota-gut-brain axis and probiotics: potential therapeutic strategies for treating Alzheimer's disease","author":"Ajith","year":"2025","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118874_bib72","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4103\/NRR.NRR-D-24-00107","article-title":"Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease","volume":"20","author":"Seplovich","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2026.118874_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.583097","article-title":"The potential roles of ghrelin in metabolic syndrome and secondary symptoms of Alzheimer's disease","volume":"14","author":"Kim","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118874_bib74","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/cells10102581","article-title":"Inflammatory Cascade in Alzheimer's disease pathogenesis: a review of experimental findings","volume":"10","author":"de Oliveira","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.118874_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-142730","article-title":"Localization and trafficking of Amyloid-\u03b2 protein precursor and secretases: impact on Alzheimer's disease","volume":"45","author":"Agostinho","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.118874_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"Muller cell degeneration and microglial dysfunction in the Alzheimer's retina","volume":"10","author":"Xu","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejmech.2026.118874_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105684","article-title":"Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease","volume":"167","author":"Kenkhuis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2026.118874_bib78","article-title":"Sex dependent effect of amyloidosis on functional network 'hub' topology is associated with downregulated neuronal gene signatures in the APP swe\/PSEN1dE9 double transgenic mouse","author":"Simon","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.118874_bib79","article-title":"Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP\/PS1 mice via the IBA1\/GFAP-MAPK signaling pathway","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118874_bib80","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920008786485227","article-title":"Artificial membrane assays to assess permeability","volume":"9","author":"Faller","year":"2008","journal-title":"Curr. Drug metab."},{"key":"10.1016\/j.ejmech.2026.118874_bib81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/108705710100600309","article-title":"High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay","volume":"6","author":"Sugano","year":"2001","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2026.118874_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:17:13Z","timestamp":1781792233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":82,"alternative-id":["S0223523426003193"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118874","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-Alzheimer's disease activity evaluation of dual 17\u03b2-HSD10 and CDK5\/p25 inhibitors based on the naphtho[2,3-b]furan-4,9-dione scaffold","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118874"}}